Radium-223 dichloride

Radium-223 dichloride is a targeted radioactive medication used to treat certain types of advanced prostate cancer that has spread to the bones. It mimics calcium and naturally locates to bone lesions affected by cancer. Once there, it emits radiation that kills nearby cancer cells while minimizing damage to healthy tissue. This helps reduce bone pain and can slow disease progression. The treatment is administered through injections and is specifically designed to deliver radiation directly to cancerous areas in the bones, offering a targeted approach that improves quality of life for patients with bone-metastatic prostate cancer.